We also confirmed thehigher expression (CD49+) and activation (CD29+) of α4β1 integrin in tumor-infiltratingCD8 T cells after NIE-NPs treatment, which were conducive to capturingof CD8 T cells by LLP2A displayed at the TME. The gene discussed is CD8A; the disease is neoplasm.